BHG Chesapeake Treatment Center BHG XLI LLC

BHG Chesapeake Treatment Center BHG XLI LLC

Services:
Gender Accepted
• Female
• Male

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient detoxification
• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient
• Intensive outpatient treatment

Ancillary Services

• Case management service
• Transportation assistance
• Suicide prevention services
• Social skills development

Type of Care

• Substance use treatment
• Detoxification

Assessment/Pre-treatment

• Outreach to persons in the community
• Screening for mental disorders
• Complete medical history/physical exam
• Screening for tobacco use
• Comprehensive substance use assessment
• Interim services for clients
• Professional interventionist/educational consultant
• Screening for substance use

Payment Assistance Available

• Payment assistance (check with facility for details)

Detoxification (medical withdrawal) Services

• Cocaine Detoxification
• Alcohol Detoxification
• Opioids detoxification
• Benzodiazepines Detoxification
• Methamphetamines detoxification
• Medication routinely used during detoxification

License/Certification/Accreditation

• State mental health department
• Drug Enforcement Agency (DEA)
• State Substance use treatment agency
• SAMHSA certification for opioid treatment program (OTP)
• The Joint Commission

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Recovery Support Services

• Recovery coach
• Assistance with obtaining social services
• Housing services

Treatment Approaches

• Matrix Model
• Anger management
• Trauma-related counseling
• 12-step facilitation
• Substance use disorder counseling
• Brief intervention
• Telemedicine/telehealth therapy
• Motivational interviewing
• Cognitive behavioral therapy
• Relapse prevention

Facility Vaping Policy

• Vaping permitted in designated area

Testing

• Testing for Hepatitis B (HBV)
• Drug and alcohol oral fluid testing
• HIV testing
• STD testing
• Breathalyzer or blood alcohol testing
• TB screening
• Testing for Hepatitis C (HCV)
• Drug or alcohol urine screening

Payment/Insurance/Funding Accepted

• Medicare
• Private health insurance
• Federal, or any government funding for substance use treatment programs
• Medicaid
• Cash or self-payment

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment
• Methadone used in Treatment

Pharmacotherapies

• Lofexidine
• Disulfiram
• Buprenorphine with naloxone
• Acamprosate (Campral®)
• Naltrexone (oral)
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone
• Clonidine
• Methadone
• Nicotine replacement

Facility Smoking Policy

• Smoking permitted in designated area

Education and Counseling Services

• Substance use disorder education
• Individual counseling
• Group counseling
• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support
• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support

Type of Opioid Treatment

• Buprenorphine maintenance
• Buprenorphine detoxification
• Maintenance service with medically supervised withdrawal after stabilization
• Methadone maintenance
• Methadone detoxification
• Relapse prevention with naltrexone
• Federally-certified Opioid Treatment Program
• Prescribes buprenorphine
• Prescribes naltrexone
• Lofexidine or Clonidine detoxification

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity